What is Inipharm?
Based in San Diego, CA, Inipharm operates within the competitive biopharmaceutical sector, focusing its research and development efforts on novel therapeutic approaches for debilitating liver conditions. The company's strategic direction is geared towards advancing its pipeline through critical development stages, aiming to bring innovative treatments to patients suffering from severe liver ailments. This focus positions Inipharm as a key player in a niche but critical area of medical research.
How much funding has Inipharm raised?
Inipharm has raised a total of $35M across 1 funding round:
Series A
$35M
Series A (2020): $35M with participation from Undisclosed
What's next for Inipharm?
The recent major strategic investment provides Inipharm with substantial resources to accelerate its research programs, potentially expand its clinical trial capabilities, and further develop its therapeutic candidates. This enterprise-level backing suggests a trajectory towards scaling operations and advancing its lead programs towards regulatory submission. The company's ability to attract significant capital indicates strong potential for future growth and market impact within the biopharmaceutical industry, particularly in the specialized field of liver disease therapeutics.
See full Inipharm company page
